Hdltherapeutics.com, 14 Websites on this Server

Hdltherapeutics.com has a Worldwide ranking of n/a Down n/a and ranking n/a in n/a. Using IP address 65.254.248.208 in and found 14 Other Websites on this Server

Hosting Provider

Website: hdltherapeutics.com
Hostname: 65-254-248-208.yourhostingaccount.com
Server Response: 29 ms
Country: United States
Region: MA
City: Burlington
Postal Code: 01803
Latitude: 42.505100250244
Longitude: -71.204696655273
Area Code: 781
Email AbuseNo Emails Found

Domains Same Server

Results for search database

We found at least 6,210 results Listing Websites below display full infomation about related content about this keyword

HDL Therapy for Treatment of ACS - HDL Therapeutics, Inc ...

  • http://hdltherapeutics.com/
  • HDL therapy is the next frontier in the fight against heart disease. HDL Therapeutics is a leader in the field of reversing coronary atherosclerosis.
  • hdltherapeutics.com

Our Therapy

  • http://hdltherapeutics.com/our-therapy-2/
  • HDL therapy is the next frontier in the fight against heart disease. HDL Therapeutics is a leader in the field of reversing coronary atherosclerosis.
  • hdltherapeutics.com

Leadership Team

  • http://hdltherapeutics.com/leadership-team/
  • HDL therapy is the next frontier in the fight against heart disease. HDL Therapeutics is a leader in the field of reversing coronary atherosclerosis.
  • hdltherapeutics.com

Contact Us

  • http://hdltherapeutics.com/contact-us/
  • HDL therapy is the next frontier in the fight against heart disease. HDL Therapeutics is a leader in the field of reversing coronary atherosclerosis.
  • hdltherapeutics.com

Publications

  • http://hdltherapeutics.com/publications/
  • HDL therapy is the next frontier in the fight against heart disease. HDL Therapeutics is a leader in the field of reversing coronary atherosclerosis.
  • hdltherapeutics.com

About Us

  • http://hdltherapeutics.com/about-us/
  • HDL therapy is the next frontier in the fight against heart disease. HDL Therapeutics is a leader in the field of reversing coronary atherosclerosis.
  • hdltherapeutics.com

News

  • http://hdltherapeutics.com/news/
  • HDL therapy is the next frontier in the fight against heart disease. HDL Therapeutics is a leader in the field of reversing coronary atherosclerosis.
  • hdltherapeutics.com

HDL Therapeutics - ABOUT US

  • http://hdltherapeutics.com/about-us/
  • HDL Therapeutics is a leader in the field of reversing coronary atherosclerosis. ACS treatment, HDL therapy, Michael Matin.
  • hdltherapeutics.com

Leadership Team - HDL Therapeutics, Inc.

  • http://hdltherapeutics.com/leadership-team/
  • Mike has been with the HDL Therapeutics, Inc. leadership team since 2013 and has more than 30 years of experience in global medical device regulatory affairs, regulatory compliance, quality assurance, and clinical research, with a particular emphasis on cardiovascular, peripheral vascular, and …
  • hdltherapeutics.com

Our Therapy - HDL Therapeutics, Inc.

  • http://hdltherapeutics.com/our-therapy-2/
  • Unmet Clinical Need Homozygous Familiar Hypercholesterolemia (HoFH) is a rare genetic disorder characterized by abnormally high levels of bad cholesterol (LDL) levels in the blood.
  • hdltherapeutics.com

Contact Us - HDL Therapeutics, Inc.

  • http://hdltherapeutics.com/contact-us/
  • © 2019 HDL Therapeutics, Inc.. Caution - Investigational Device, Limited by Federal Law to Investigational Use.
  • hdltherapeutics.com

News - HDL Therapeutics, Inc.

  • http://hdltherapeutics.com/news/
  • HDL Therapeutics appoints Michael P. Winegar Vice President, Regulatory Affairs & Quality Assurance. June 9, 2014 HDL Therapeutics, Inc. announces the initiation of Series B Private Placement.
  • hdltherapeutics.com

HDL Therapeutics, Inc.: Private Company Information ...

  • https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=228496541
  • Feb 13, 2019 · HDL Therapeutics, Inc., a cardiovascular device company, develops acute care therapeutic devices for the treatment of patients with acute coronary syndrome disease. It …
  • www.bloomberg.com

Publications - HDL Therapeutics, Inc.

  • http://hdltherapeutics.com/publications/
  • Publications A First in Man, Randomized, Placebo Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High Density Lipoprotein Plasma Infusions in …
  • hdltherapeutics.com

Hdl therapeutics | Crunchbase

  • https://www.crunchbase.com/organization/hdl-therapeutics
  • HDL Therapeutics is a cardiovascular device company specializing in the field of reversing coronary atherosclerosis. Short Hills, New Jersey, United States. Categories . Biotechnology, Medical Device, Therapeutics. Headquarters Regions . Greater New York Area, …
  • www.crunchbase.com

HDL Therapeutics, Inc.: CEO and Executives - Bloomberg

  • https://www.bloomberg.com/research/stocks/private/people.asp?privcapId=228496541
  • HDL Therapeutics, Inc. CEO Compensation. Industry Average. INDUSTRY EXECUTIVE CHANGES. Sue Bostrom to Retire from the Varian Medical Systems Board at …
  • www.bloomberg.com

Title & MetaTags

title:HDL Therapy for Treatment of ACS - HDL Therapeutics, Inc. - Welcome
viewport:initial-scale=1,user-scalable=no,maximum-scale=1,width=device-width
description:HDL therapy is the next frontier in the fight against heart disease. HDL Therapeutics is a leader in the field of reversing coronary atherosclerosis.
  H1 (2)
  • Welcome
  H2 (1)
  H3 (0)
      H4 (0)

      Not Found